{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05735717",
            "orgStudyIdInfo": {
                "id": "2021LS061"
            },
            "organization": {
                "fullName": "Masonic Cancer Center, University of Minnesota",
                "class": "OTHER"
            },
            "briefTitle": "MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies",
            "officialTitle": "Phase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood Stem Cell (PBSC) Transplantation for Children and Adults With Hematological Malignancies",
            "therapeuticArea": [
                "Rare Diseases",
                "Oncology and Hematology",
                "Other"
            ],
            "study": "cell-receptor-alpha-beta-depletion-pbsc-transplantation-for-heme-malignancies"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2023-05-11",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-11-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-11-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-01-10",
            "studyFirstSubmitQcDate": "2023-02-09",
            "studyFirstPostDateStruct": {
                "date": "2023-02-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-02",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Masonic Cancer Center, University of Minnesota",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a phase II, open-label, prospective study of T cell receptor alpha/beta depletion (\u03b1/\u03b2 TCD) peripheral blood stem cell (PBSC) transplantation for children and adults with hematological malignancies"
        },
        "conditionsModule": {
            "conditions": [
                "Hematologic Malignancy",
                "Acute Leukemia",
                "Remission",
                "Acute Myeloid Leukemia",
                "Acute Lymphoblastic Leukemia",
                "AML",
                "TP53",
                "Intrachromosomal Amplification of Chromosome 21",
                "Cytogenetic Abnormality",
                "CNS Leukemia",
                "Minimal Residual Disease",
                "Myelodysplasia",
                "Juvenile Myelomonocytic Leukemia",
                "Somatic Mutation",
                "PTPN11 Gene Mutation",
                "N-RAS Gene Amplification",
                "Neurofibromatosis 1",
                "NF1 Mutation",
                "CBL Gene Mutation",
                "Monosomy 7",
                "Chromosome Abnormality",
                "Fetal Hemoglobin"
            ],
            "keywords": [
                "Bu",
                "Flu",
                "G-CSF",
                "GFSR",
                "aGVHD",
                "HCT",
                "MAC",
                "Mel",
                "PBSCT",
                "PTLD",
                "RECIST",
                "TCR"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 150,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Fludarabine (flu), Total Body Irradiation (TBI), Flu/TBI Regimen",
                    "type": "EXPERIMENTAL",
                    "description": "Patients will be treated on the most medically appropriate regimen with a preference for Flu/TBI Arm followed by an infusion at Day 0 of Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells.",
                    "interventionNames": [
                        "Drug: Fludarabine",
                        "Drug: Rituximab"
                    ]
                },
                {
                    "label": "Fludarabine (flu), Busulfan (bu), Flu/Bu Regimen",
                    "type": "EXPERIMENTAL",
                    "description": "Patients will be treated on the most medically appropriate regimen with a preference for Flu/TBI Arm followed by an infusion at Day 0 of Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells.",
                    "interventionNames": [
                        "Drug: Fludarabine",
                        "Drug: Busulfan",
                        "Drug: Rituximab",
                        "Drug: Levetiracetam"
                    ]
                },
                {
                    "label": "Fludarabine (flu), Busulfan (bu), Melphalan (Mel) Regimen for Pediatric Patients Only",
                    "type": "EXPERIMENTAL",
                    "description": "Flu/Bu/Mel will the preference for patients with JMML or infants with leukemia.",
                    "interventionNames": [
                        "Drug: Fludarabine",
                        "Drug: Busulfan",
                        "Drug: Melphalan",
                        "Drug: Rituximab",
                        "Drug: Levetiracetam"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Fludarabine",
                    "description": "Fludarabine 25mg/m2 IV on days -8 to -6 or days -4 to -2. 40mg/m2 IV on days -5 to -2.",
                    "armGroupLabels": [
                        "Fludarabine (flu), Busulfan (bu), Flu/Bu Regimen",
                        "Fludarabine (flu), Busulfan (bu), Melphalan (Mel) Regimen for Pediatric Patients Only",
                        "Fludarabine (flu), Total Body Irradiation (TBI), Flu/TBI Regimen"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Busulfan",
                    "description": "Busulfan 82.1 mg\\*hr/L IV on days -5 to -2 or days -8 to -5",
                    "armGroupLabels": [
                        "Fludarabine (flu), Busulfan (bu), Flu/Bu Regimen",
                        "Fludarabine (flu), Busulfan (bu), Melphalan (Mel) Regimen for Pediatric Patients Only"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Melphalan",
                    "description": "Melphalan 50 mg/m2 IV on days -4 to -2",
                    "armGroupLabels": [
                        "Fludarabine (flu), Busulfan (bu), Melphalan (Mel) Regimen for Pediatric Patients Only"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Rituximab",
                    "description": "200 mg/m2 intravenous given once on day-1",
                    "armGroupLabels": [
                        "Fludarabine (flu), Busulfan (bu), Flu/Bu Regimen",
                        "Fludarabine (flu), Busulfan (bu), Melphalan (Mel) Regimen for Pediatric Patients Only",
                        "Fludarabine (flu), Total Body Irradiation (TBI), Flu/TBI Regimen"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Levetiracetam",
                    "description": "As seizures have occurred following high dose busulfan, all patients will be treated with Keppra beginning day -6 and continuing until day -1 per institutional guidelines.",
                    "armGroupLabels": [
                        "Fludarabine (flu), Busulfan (bu), Flu/Bu Regimen",
                        "Fludarabine (flu), Busulfan (bu), Melphalan (Mel) Regimen for Pediatric Patients Only"
                    ],
                    "otherNames": [
                        "Keppra"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Determine the rate of GVHD after alpha beta TCR depletion",
                    "description": "GVHD incidence after treatment.",
                    "timeFrame": "85 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Transplant engraftment",
                    "description": "Monitor median rate of engraftment by 42 days.",
                    "timeFrame": "42 days"
                },
                {
                    "measure": "Graft Failure",
                    "description": "Determine the rate of graft failure by day 100 (defined as lack of achievement of an ANC \\>=500/mL with associated pancytopenia)",
                    "timeFrame": "100 days"
                },
                {
                    "measure": "Non-relapse mortality (NRM)",
                    "description": "Determine the incidence of non-relapse mortality (NRM) at 100 days and 1 year",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Overall survival (OS)",
                    "description": "Number of participants experiencing progression free survival at one year follow up",
                    "timeFrame": "12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Histological confirmation of hematological malignancies\n* Acute leukemias\n* Acute Myeloid Leukemia (AML) and related precursor neoplasms\n* Favorable risk AML is defined as having one of the following:\n* Acute lymphoblastic leukemia (ALL)/lymphoma\n* Myelodysplasia (MDS) IPSS INT-2 or High Risk (i.e. RAEB, RAEBt) or Refractory Anemia with severe pancytopenia, transfusion dependence, or high risk cytogenetics or molecular features.\n* Age 60 years of age or younger at the time of consent\n* Karnofsky performance status \u2265 70% or Lansky play score 50% for \u226416 years of age.\n* Adequate organ function\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding.\n* Active uncontrolled infection within 1 week of starting preparative therapy\n* Known seropositive for HIV or known active Hepatitis B or C infection with detectable viral load by PCR.\n* Any prior autologous or allogeneic transplant\n* CML blast crisis\n* Active central nervous system malignancy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "maximumAge": "60 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Margaret MacMillan",
                    "role": "CONTACT",
                    "phone": "612-626-2961",
                    "email": "macmi002@umn.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Margaret MacMillan",
                    "affiliation": "University of Minnesota Masonic Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Minnesota Masonic Cancer Center",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55455",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Margaret MacMillan",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "For the purposes of data and safety monitoring, this study is classified as high risk (investigator initiated under an IND). Therefore the following requirements will be fulfilled:\n\n* The Masonic Cancer Center Data and Safety Monitoring Council (DSMC) will review the study's progress at least quarterly.\n* The PI will comply with at least twice yearly monitoring of the project by the Masonic Cancer Center monitoring services.\n* The PI will oversee the submission of all reportable adverse events per the definition of reportable in Section 11.5 to the Masonic Cancer Center's SAE Coordinator, the University of Minnesota IRB, and the FDA."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007938",
                    "term": "Leukemia"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000054198",
                    "term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma"
                },
                {
                    "id": "D000019337",
                    "term": "Hematologic Neoplasms"
                },
                {
                    "id": "D000017253",
                    "term": "Neurofibromatoses"
                },
                {
                    "id": "D000009456",
                    "term": "Neurofibromatosis 1"
                },
                {
                    "id": "D000018365",
                    "term": "Neoplasm, Residual"
                },
                {
                    "id": "D000054429",
                    "term": "Leukemia, Myelomonocytic, Juvenile"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                },
                {
                    "id": "D000025063",
                    "term": "Chromosome Disorders"
                },
                {
                    "id": "D000002869",
                    "term": "Chromosome Aberrations"
                },
                {
                    "id": "D000009006",
                    "term": "Monosomy"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000007951",
                    "term": "Leukemia, Myeloid"
                },
                {
                    "id": "D000007945",
                    "term": "Leukemia, Lymphoid"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009455",
                    "term": "Neurofibroma"
                },
                {
                    "id": "D000018317",
                    "term": "Nerve Sheath Neoplasms"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                },
                {
                    "id": "D000009386",
                    "term": "Neoplastic Syndromes, Hereditary"
                },
                {
                    "id": "D000020752",
                    "term": "Neurocutaneous Syndromes"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000020271",
                    "term": "Heredodegenerative Disorders, Nervous System"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000010523",
                    "term": "Peripheral Nervous System Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000009385",
                    "term": "Neoplastic Processes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000001855",
                    "term": "Bone Marrow Diseases"
                },
                {
                    "id": "D000054437",
                    "term": "Myelodysplastic-Myeloproliferative Diseases"
                },
                {
                    "id": "D000000782",
                    "term": "Aneuploidy"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10295",
                    "name": "Influenza, Human",
                    "relevance": "LOW"
                },
                {
                    "id": "M21314",
                    "name": "Hematologic Neoplasms",
                    "asFound": "Hematologic Malignancies",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27585",
                    "name": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
                    "asFound": "Acute Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "asFound": "Abnormalities",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "asFound": "Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10951",
                    "name": "Leukemia, Lymphoid",
                    "relevance": "LOW"
                },
                {
                    "id": "M19549",
                    "name": "Neurofibromatoses",
                    "asFound": "Neurofibromatosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12399",
                    "name": "Neurofibromatosis 1",
                    "asFound": "Neurofibromatosis 1",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27706",
                    "name": "Leukemia, Myelomonocytic, Juvenile",
                    "asFound": "Juvenile Myelomonocytic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20497",
                    "name": "Neoplasm, Residual",
                    "asFound": "Minimal Residual Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12398",
                    "name": "Neurofibroma",
                    "relevance": "LOW"
                },
                {
                    "id": "M10955",
                    "name": "Leukemia, Myeloid",
                    "relevance": "LOW"
                },
                {
                    "id": "M18127",
                    "name": "Leukemia, Myeloid, Acute",
                    "relevance": "LOW"
                },
                {
                    "id": "M14164",
                    "name": "Preleukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M12145",
                    "name": "Myelodysplastic Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M6109",
                    "name": "Chromosome Aberrations",
                    "asFound": "Chromosome Abnormalities",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11968",
                    "name": "Monosomy",
                    "asFound": "Monosomy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M23023",
                    "name": "Chromosome Disorders",
                    "asFound": "Chromosome Abnormalities",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M20461",
                    "name": "Nerve Sheath Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M12331",
                    "name": "Neoplastic Syndromes, Hereditary",
                    "relevance": "LOW"
                },
                {
                    "id": "M22509",
                    "name": "Neurocutaneous Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M22092",
                    "name": "Heredodegenerative Disorders, Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M13432",
                    "name": "Peripheral Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12330",
                    "name": "Neoplastic Processes",
                    "relevance": "LOW"
                },
                {
                    "id": "M5134",
                    "name": "Bone Marrow Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12149",
                    "name": "Myeloproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M27707",
                    "name": "Myelodysplastic-Myeloproliferative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4112",
                    "name": "Aneuploidy",
                    "relevance": "LOW"
                },
                {
                    "id": "T175",
                    "name": "Acute Lymphoblastic Leukemia",
                    "asFound": "Acute Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3533",
                    "name": "Lymphoblastic Lymphoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T4096",
                    "name": "Neurofibromatosis",
                    "asFound": "Neurofibromatosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4097",
                    "name": "Neurofibromatosis Type 1",
                    "asFound": "Neurofibromatosis 1",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1310",
                    "name": "Chronic Myelomonocytic Leukemia",
                    "asFound": "Juvenile Myelomonocytic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3174",
                    "name": "Juvenile Myelomonocytic Leukemia",
                    "asFound": "Juvenile Myelomonocytic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3995",
                    "name": "Myeloid Leukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "T4095",
                    "name": "Neurofibroma",
                    "relevance": "LOW"
                },
                {
                    "id": "T182",
                    "name": "Acute Myeloid Leukemia",
                    "asFound": "Acute Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T188",
                    "name": "Acute Non Lymphoblastic Leukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "T3993",
                    "name": "Myelodysplastic Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T1311",
                    "name": "Chronic Myeloproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T3994",
                    "name": "Myelodysplastic/myeloproliferative Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000069283",
                    "term": "Rituximab"
                },
                {
                    "id": "C000024352",
                    "term": "Fludarabine"
                },
                {
                    "id": "D000008558",
                    "term": "Melphalan"
                },
                {
                    "id": "D000002066",
                    "term": "Busulfan"
                },
                {
                    "id": "D000077287",
                    "term": "Levetiracetam"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                },
                {
                    "id": "D000019653",
                    "term": "Myeloablative Agonists"
                },
                {
                    "id": "D000000927",
                    "term": "Anticonvulsants"
                },
                {
                    "id": "D000018697",
                    "term": "Nootropic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11541",
                    "name": "Melphalan",
                    "asFound": "Controlled Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M373",
                    "name": "Rituximab",
                    "asFound": "Infusion",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5336",
                    "name": "Busulfan",
                    "asFound": "Anesthetic",
                    "relevance": "HIGH"
                },
                {
                    "id": "M283230",
                    "name": "Fludarabine",
                    "asFound": "Rate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M225513",
                    "name": "Fludarabine phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M1741",
                    "name": "Levetiracetam",
                    "asFound": "Activated",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4246",
                    "name": "Anticonvulsants",
                    "relevance": "LOW"
                },
                {
                    "id": "M20774",
                    "name": "Nootropic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "AntiConv",
                    "name": "Anticonvulsants"
                },
                {
                    "abbrev": "NootAg",
                    "name": "Nootropic Agents"
                }
            ]
        }
    },
    "hasResults": false
}